CD8A and neoplasm: Compared to conventional treatment for oral or head and neck cancers, adoptive transfer-based immunotherapy is a relatively specific approach directed to tumor cells through the activated effectors such as CD8+ T cells, in an antigen-dependent manner [3]–[4].